CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
113 hedge funds and large institutions have $3.78B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 107 → 113 (+6)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
113
Holding in Top 10
2
Calls
$16M
Puts
$12.4M
Top Buyers
| 1 | +$77.8M | |
| 2 | +$40.3M | |
| 3 | +$30.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.3M |
Top Sellers
| 1 | -$43.5M | |
| 2 | -$43.1M | |
| 3 | -$11.3M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$4.5M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.96M |